Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Scott O'Gorman, Andy Colyer, Daniel WhiteIthaka US Growth Strategy | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Ithaka US Growth Strategy - ISRG Intuitive Surgical is a pioneering medical technology company best known for its da Vinci robotic surgical system, which enables surgeons to perform precise, minimally invasive procedures. The system is... | NEUTRAL | View Pitch → |
| Sep 2, 2026 | Fund Letter | Neal KaufmanBaron Health Care Fund | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Baron Health Care Fund - ISRG Intuitive Surgical, Inc. sells robotic-assisted surgical systems. Shares declined after... | BEAR | View Pitch → |
| Sep 2, 2026 | Fund Letter | Brandon D. Bond, Bo Fifer, Brian M. McNamaraTCW Concentrated Large Cap Growth Fund | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | TCW Concentrated Large Cap Growth Fund - ISRG Shares of Intuitive Surgical, Inc. (ISRG; 1.93%) moved lower despite releasing solid quarterly results. Revenue and Da... | NEUTRAL | View Pitch → |
| Sep 2, 2026 | Fund Letter | Alan BreedEdgewood Management | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Edgewood Management - ISRG Intuitive Surgical showed 38% year-over-year EPS growth in the most recent quarter. Portfolio weighting is... | NEUTRAL | View Pitch → |
| Sep 2, 2026 | Fund Letter | Brian A. Christiansen, David E. Levanson, Daniel PillingSands Capital Global Growth Fund | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Sands Capital Global Growth Fund - ISRG Intuitive Surgical is a leading provider of robotic surgical systems. Shares came under... | NEUTRAL | View Pitch → |
| Sep 2, 2026 | Fund Letter | Alex UmanskyBaron Fifth Avenue Growth Fund | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Baron Fifth Avenue Growth Fund - ISRG Intuitive Surgical, Inc. sells robotic-assisted surgical systems. Shares declined 13.7%... | BEAR | View Pitch → |
| Aug 21, 2026 | Fund Letter | Alan BreedEdgewood Management | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long ISRG (Intuitive Surgical Inc.) The company's leading position in robotic-assisted surgery continues to support durable high-teens revenue growth and strong earnings compounding. The manager views... | BULL | View Pitch → |
| Aug 21, 2026 | Fund Letter | Alex Gunz | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long ISRG (Intuitive Surgical, Inc.) As the pioneer of minimally invasive robotic surgery, Intuitive Surgical boasts a massive global installed base and an highly compelling razor-and-blade business model. Over 80% of... | BULL | View Pitch → |
| Feb 25, 2026 | Fund Letter | Alan BreedEdgewood Management | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Edgewood Management 2025 Q3 (ISRG) Global leader in robotic-assisted surgical systems, instruments and accessories with its da Vinci and Ion endoluminal platforms. Thesis: ISRG benefits... | BULL | View Pitch → |
| Jan 28, 2026 | Fund Letter | Brown Advisory LLCBrown Advisory Large-Cap Growth Strategy | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Brown Advisory Large-Cap Growth Strategy 2025 Q4 (ISRG) Intuitive Surgical delivered strong quarterly results that eased concerns around hospital spending and procedure growth. Procedure volumes rose... | BULL | View Pitch → |
| Jan 23, 2026 | Fund Letter | Scott O'Gorman, Andy Colyer, Daniel WhiteIthaka US Growth Strategy | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Ithaka US Growth Strategy 2025 Q4 (ISRG) Intuitive Surgical is a pioneering medical technology company best known for its da Vinci robotic surgical system, which enables surgeons to perform precise, minimally invasive procedures. The system is... | BULL | View Pitch → |
| Jan 8, 2026 | Fund Letter | Shawn Jakupi, Mehendi KamaniTall Oak Capital Advisors | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Tall Oak Capital Advisors 2025 Q2 (ISRG) Intuitive Surgical continues to be a prime beneficiary of the shift toward minimally invasive care — a preference that's particularly pronounced among aging patients and hospitals managing resource constraints. The company's Da... | BULL | View Pitch → |
| Jan 7, 2026 | Fund Letter | Alex UmanskyBaron Fifth Avenue Growth Fund | Intuitive Surgical $ISRG• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Baron Fifth Avenue Growth Fund 2025 Q3 (ISRG) Intuitive Surgical, Inc. manufactures the da Vinci robotic surgical system for minimally invasive surgical procedures. Shares detracted from... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.